Breaking News

Vetio Awarded Cannabis Research License from Health Canada

Begins development of cannabis-based veterinary drug products in Montreal

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Vetio, a contract development and manufacturing organization (CDMO) dedicated to animal health, has been issued a cannabis research license by Health Canada under the Cannabis Act and Cannabis Regulations.   “With this license, we are now able to bring Vetio’s expertise to the emerging field of therapeutic cannabis-based products,” said John Kane, chief executive officer, Vetio. “We believe that cannabis-based products will be vital to animal health, and Vetio is committed to bring solutions to ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters